Iofolastat (123 I) Uses, Dosage, Side Effects and more
Iofolastat (123 I) is under investigation in clinical trial NCT00992745 (A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Iofolastat (123 I) |
| Generic | Iofolastat I-123 |
| Iofolastat I-123 Other Names | Iofolastat (123 I) |
| Type | |
| Formula | C19H26IN3O7 |
| Weight | Average: 531.337 Monoisotopic: 531.082673133 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
